Alembic Pharma iron tablet Deferasirox gets USFDA nod Ruchika Sharma16 Jun 2020 2:58 PM ISTDeferasirox tablets are indicated for the treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron Overload) and for treatment...
USFDA ends emergency use of hydroxychloroquine to treat Covid-19 MD Bureau16 Jun 2020 12:37 AM ISTThe drugs are traditionally used to treat malaria and certain autoimmune conditions, including lupus and rheumatoid arthritis. These can be taken to...
Lupin to approach USFDA for re-inspection of Goa, Pithampur, US plant Ruchika Sharma15 Jun 2020 12:12 PM ISTThe US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of...
Dr Reddy's Labs launches Colchicine Tablets in US Ruchika Sharma13 Jun 2020 12:34 PM ISTDr. Reddy's Colchicine is available in 0.6 mg tablets in bottle count sizes of 30s and 1 00s
Caplin Steriles gets USFDA nod for generic VAZCULEP injection Ruchika Sharma13 Jun 2020 11:00 AM ISTPhenylephrine Hydrochloride Injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the...
Biocon, Mylan get USFDA approval for insulin glargine injection Semglee Ruchika Sharma12 Jun 2020 1:17 PM ISTSemglee has an identical amino acid sequence to Sanofi's Lantus® and is approved for the same indications
Lupin gets USFDA nod to anthelmintic drug Albendazole Ruchika Sharma12 Jun 2020 12:34 PM ISTMumbai, Baltimore: Drug maker Lupin Limited has received approval for its Albendazole Tablets USP, 200 mg, from the United States Food and Drug...
Lupin Mexiletine Hydrochloride gets Orphan Drug Designation from USFDA Ruchika Sharma9 Jun 2020 11:04 AM ISTMexiletine reduces myotonia symptoms, resulting in a significant improvement in patient quality-of-life and other functional outcomes
Zydus Cadila gets final USFDA nod to HIV infection drug Atazanavir Ruchika Sharma6 Jun 2020 11:29 AM ISTAtazanavir, an antiretroviral drug, is used to treat infection of the Human Immunodeficiency Virus (HIV)
Aurobindo Pharma USA facility gets 9 USFDA observations Ruchika Sharma5 Jun 2020 12:52 PM ISTThe company believes that this OAI classification may not have any material impact on the existing revenues, the supplies of our US business, or...
FDA grants breakthrough designation to wearable device for Restless Legs Syndrome Dr. Kamal Kant Kohli5 Jun 2020 11:43 AM ISTSAN FRANCISCO - Noctrix Health, Inc., a privately held medical device company announced today that the US Food and Drug Administration (FDA) has...
Mylan, Revance to Advance Development Program for Biosimilar to BOTOX Ruchika Sharma5 Jun 2020 9:00 AM ISTMylan and Revance signed a collaboration and license agreement in February 2018 for the development and regulatory approval of a biosimilar to BOTOX,...
